View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. 2018
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
  17. Published
  18. 2017
  19. Published
  20. Published
  21. Published
  22. 2016
  23. Published
  24. Published
  25. Published
  26. Published
  27. Published
  28. Published
  29. 2015
  30. Published
  31. Published
    Adriaanse, M. P. M., van der Sande, L. J. T. M., van den Neucker, A. M., Menheere, P. P. C. A., Dompeling, E., Buurman, W. A., & Vreugdenhil, A. C. E. (2015). Evidence for a Cystic Fibrosis Enteropathy. PLOS ONE, 10(10), [e0138062]. https://doi.org/10.1371/journal.pone.0138062
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. Published
    Gross, S., Adriaanse, M. P., Nijeboer, P., Tack, G. J., van Hoogstraten, I. M., Bouma, G., ... Bontkes, H. J. (2015). Serum intestinal-fatty acid binding protein as a biomarker for refractory celiac disease. Journal of Gastrointestinal and Liver Diseases, 24(2), 258-259.
  38. 2014
  39. Published
    Vreugdenhil, A. C. (2014). Hepatitis. In Werkboek KinderMDL Amsterdam: VU Boekhandel / UItgeverij BV.
  40. Published
    Adriaanse, M. P., Vreugdenhil, A. C., Groeneweg, M., Bruggenwirth, H. T., Castelijns, S. J., van der Ent, C. K., ... Tilanus, M. G. (2014). HLA frequencies and associations in cystic fibrosis. Tissue Antigens, 83(1), 27-31. https://doi.org/10.1111/tan.12265
  41. Published
  42. Published
    Vreugdenhil, A. (2014). Pancreasaandoeningen. In Werkboek KinderMDL VU Boekhandel / UItgeverij BV.
  43. Published
  44. 2013
  45. Published
    Tack, G. J., van de Water, J. M., Bruins, M. J., Kooy-Winkelaar, E. M., van Bergen, J., Bonnet, P., ... Koning, F. (2013). Consumption of gluten with gluten-degrading enzyme by celiac patients: A pilot-study. World Journal of Gastroenterology, 19(35), 5837-5847. https://doi.org/10.3748/wjg.v19.i35.5837
  46. Published
  47. Published
  48. 2012
  49. Published
  50. 2011
  51. Published
    Vreugdenhil, A. C. E., Wolters, V. M., Adriaanse, M. P., van den Neucker, A. M., van Bijnen, A. A., Houwen, R., & Buurman, W. A. (2011). Additional value of serum i-fabp levels for evaluating celiac disease activity in children. Scandinavian Journal of Gastroenterology, 46(12), 1435-1441. https://doi.org/10.3109/00365521.2011.627447
  52. Published
    De Bie, C. I., Hummel, T. Z., Kindermann, A., Kokke, F. T., Damen, G. M., Kneepkens, C. M., ... De Ridder, L. (2011). The duration of effect of infliximab maintenance treatment in paediatric Crohn's disease is limited. Alimentary Pharmacology & Therapeutics, 33(2), 243-250. https://doi.org/10.1111/j.1365-2036.2010.04507.x
  53. 2010
  54. Published
    Vreugdenhil, A. C. E., van Mil, E. G., & van Heurn, L. W. E. (2010). Een extreem dik kind: is operatieve behandeling wenselijk? In Praktische Pediatrie, Nr. 2
  55. 2009
  56. Published
  57. 2007
  58. Published
    De Backer, I. C., van Breda, E., Vreugdenhil, A. C. E., Nijziel, M. R., Kester, A. D. M., & Schep, G. (2007). High-intensity strength training improves quality of life in cancer survivors. Acta Oncologica, 46(8), 1143-1151. https://doi.org/10.1080/02841860701418838
  59. 2004
  60. Published
  61. 2003
  62. Published
  63. Published
  64. 2001
  65. Published
Previous 1 2 Next